Research ArticleArticle
All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement
Aryeh Fischer, Amanda M. Kong, Jeffrey J. Swigris, Ashley L. Cole and Karina Raimundo
The Journal of Rheumatology November 2017, jrheum.170307; DOI: https://doi.org/10.3899/jrheum.170307
Aryeh Fischer
From the University of Colorado School of Medicine, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; National Jewish Health, Denver, Colorado; Genentech Inc., South San Francisco, California, USA. This analysis was funded by Genentech Inc., and F. Hoffmann-La Roche Ltd. A. Fischer, MD, University of Colorado School of Medicine; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; J.J. Swigris, DO, MS, National Jewish Health; A.L. Cole, MPH, Truven Health Analytics; K. Raimundo, MS, Genentech Inc. Address correspondence to K. Raimundo, Genentech, 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 11, 2017.
Amanda M. Kong
From the University of Colorado School of Medicine, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; National Jewish Health, Denver, Colorado; Genentech Inc., South San Francisco, California, USA. This analysis was funded by Genentech Inc., and F. Hoffmann-La Roche Ltd. A. Fischer, MD, University of Colorado School of Medicine; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; J.J. Swigris, DO, MS, National Jewish Health; A.L. Cole, MPH, Truven Health Analytics; K. Raimundo, MS, Genentech Inc. Address correspondence to K. Raimundo, Genentech, 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 11, 2017.
Jeffrey J. Swigris
From the University of Colorado School of Medicine, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; National Jewish Health, Denver, Colorado; Genentech Inc., South San Francisco, California, USA. This analysis was funded by Genentech Inc., and F. Hoffmann-La Roche Ltd. A. Fischer, MD, University of Colorado School of Medicine; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; J.J. Swigris, DO, MS, National Jewish Health; A.L. Cole, MPH, Truven Health Analytics; K. Raimundo, MS, Genentech Inc. Address correspondence to K. Raimundo, Genentech, 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 11, 2017.
Ashley L. Cole
From the University of Colorado School of Medicine, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; National Jewish Health, Denver, Colorado; Genentech Inc., South San Francisco, California, USA. This analysis was funded by Genentech Inc., and F. Hoffmann-La Roche Ltd. A. Fischer, MD, University of Colorado School of Medicine; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; J.J. Swigris, DO, MS, National Jewish Health; A.L. Cole, MPH, Truven Health Analytics; K. Raimundo, MS, Genentech Inc. Address correspondence to K. Raimundo, Genentech, 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 11, 2017.
Karina Raimundo
From the University of Colorado School of Medicine, Denver, Colorado; Truven Health Analytics, an IBM Company, Cambridge, Massachusetts; National Jewish Health, Denver, Colorado; Genentech Inc., South San Francisco, California, USA. This analysis was funded by Genentech Inc., and F. Hoffmann-La Roche Ltd. A. Fischer, MD, University of Colorado School of Medicine; A.M. Kong, MPH, Truven Health Analytics, an IBM Company; J.J. Swigris, DO, MS, National Jewish Health; A.L. Cole, MPH, Truven Health Analytics; K. Raimundo, MS, Genentech Inc. Address correspondence to K. Raimundo, Genentech, 1 DNA Way, South San Francisco, California 94080, USA. E-mail: raimundo.karina@gene.com. Accepted for publication August 11, 2017.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
All-cause Healthcare Costs and Mortality in Patients with Systemic Sclerosis with Lung Involvement
Aryeh Fischer, Amanda M. Kong, Jeffrey J. Swigris, Ashley L. Cole, Karina Raimundo
The Journal of Rheumatology Nov 2017, jrheum.170307; DOI: 10.3899/jrheum.170307